Organization · Venture Capital
Adaptive Capital Partners
Adaptive Capital Partners is a Singapore-based early-stage venture capital firm focused on healthtech and medtech investments. The firm emphasizes operational support and technical diligence for startups in Southeast Asia and beyond.
Overview
What Adaptive Capital Partners does
What Adaptive Capital Partners is
Adaptive Capital Partners is a Singapore-based early-stage venture capital firm focused on healthtech and medtech investments. The firm emphasizes operational support and technical diligence for startups in Southeast Asia and beyond.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Adaptive Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Adaptive Capital Partners as a funder
Investment thesis
Adaptive Capital Partners invests in high-conviction, disruptive technology startups, focusing on healthtech and medtech. The firm emphasizes deep operator experience and hands-on support for founders, particularly in AI diagnostics, preventive care, and clinical-grade wearables.
Focus narrative
The firm targets early-stage investments, including seed and Series A rounds, with a strong emphasis on healthtech, medtech, and AI-driven solutions. Adaptive Capital Partners seeks to partner with founders who have a defensible clinical or technical edge and are prepared for rigorous due diligence processes.
Value beyond capital
Adaptive Capital Partners provides operational support and technical diligence to its portfolio companies, helping them address company-building challenges and navigate regulatory complexities. The firm emphasizes a hands-on approach to investment, ensuring that startups are well-prepared for growth and market entry.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Regions
- Southeast Asia · United States · Greater China
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: Respiree: A healthtech company developing AI platforms for disease-progression monitoring, which raised $11.6M in Series A funding. Biorithm: A women's health medtech firm focused on remote maternal/fetal monitoring, co-leading a $3.5M Series A round. AOA Dx: An ovarian-cancer diagnostics company that secured $17.2M in funding, with Adaptive as a key investor. FIND Neuro: An AI platform for epilepsy surgery planning, showcasing clinical validation progress.
Common questions
What to know about Adaptive Capital Partners
Upseed classifies Adaptive Capital Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.